Recent Updates
Recently added Catalysts
EBS Positive Sentiment Score: 70/100

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

Key Takeaway: Emergent BioSolutions Inc. will host a conference call on August 5, 2026, to discuss its financial results for the second quarter of 2026. Participants can join via webcast or telephone after registering in advance. The company emphasizes its mission to protect public health through various life-saving solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions will report its financial results, indicating ongoing operations.
  • The company continues to engage with investors through a scheduled conference call.
  • The focus on public health solutions highlights the company's commitment to safety.

Full Press Release Details

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the second quarter of 2026.
Participants can access the conference call live viawebcastand also by visiting theInvestorspage of Emergent’s website. To participate via telephone, please register in advance at thislink. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from theInvestorspage of Emergent’s website.
About Emergent BioSolutionsAt Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit ourwebsiteand follow us onLinkedIn,X,Instagram,Apple PodcastsandSpotify.

Investor Contact:Richard S. LindahlExecutive Vice President, CFOlindahlr@ebsi.com

Media Contact:Assal HellmerVice President, Communicationsmediarelations@ebsi.com

Frequently Asked Questions

When will Emergent BioSolutions report its Q2 2026 results?

Emergent BioSolutions will report its Q2 2026 financial results on August 5, 2026.

How can I participate in the conference call?

Participants can join the call via webcast or telephone after registering in advance.

What is the purpose of the conference call?

The call will discuss the financial results for the second quarter of 2026.

Where can I find the replay of the call?

A replay of the call will be available on the Investors page of Emergent's website.

Last updated: Jul 22, 2026